Understanding the cellular mechanisms involved in the regulation of leptin and IGF-1 expression levels is paramount for the search of agents that protect against AD by reducing Aβ accumulation and subsequent deleterious effects. The gene discussed is LEP; the disease is Alzheimer disease.